Regeneron Pharmaceuticals (REGN)

$940.88 3.27 (0.35%)

10:16 EDT REGN Stock Quote Delayed 30 Minutes

Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar

By Matthew Farley, InvestorPlace Contributor May 3, 2024

Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.

REGN Stock Earnings: Regeneron Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024

3 Biotech Stocks to Buy for the Next Bull Run: March 2024

Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs

More Articles

Volume:

Previous Close -

Market Cap 86.35B

PE Ratio 27.79

EPS 33.86

Volume (Avg. Vol.) 56,070

Day's Range $926.94 - $947.08

52-Week Range $684.80 - $998.33

Dividend & Yield N/A (N/A)

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

From InvestorPlace
From the Web

The 3 Most Undervalued Biotech Stocks to Buy in March 2024

By Chandler Capital, InvestorPlace Contributor Mar 13, 2024

These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March.

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits

By Will Ashworth, InvestorPlace Contributor Mar 4, 2024

Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.

3 Top Pharma Stocks to Buy Now: February 2024

By Rick Orford, InvestorPlace Contributor Feb 1, 2024

Take a look at why these three buy-rated pharma stocks could be your ticket to explosive portfolio growth.

3 Blue-Chip Healthcare Stocks to Buy and Hold Forever: January 2024

By Jeremy Flint, InvestorPlace Contributor Jan 23, 2024

Blue-chip healthcare stocks combine stability, profitability, and long-term growth prospects into a single investable package.

Healthcare Heroes: 3 Biotech Stocks Poised to Cure What Ails the Market

By Jeremy Flint, InvestorPlace Contributor Jan 16, 2024

Biotech stocks are set to rebound in 2024 as the FDA accelerates its approval pace and cash flows back into the industry.

7 Undervalued Nasdaq-100 Stocks for Bargain Hunters

By Josh Enomoto, InvestorPlace Contributor Dec 21, 2023

Understandably, with the innovation sector printing a remarkable performance, all eyes have centered on Nasdaq-100 stocks. Indeed, on a year-to-date basis, the index shot up…

7 Underappreciated Biotech Stocks to Pick Up on the Cheap

By Josh Enomoto, InvestorPlace Contributor Nov 9, 2023

Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader…

The 7 Best Value Stocks to Buy in August

By Josh Enomoto, InvestorPlace Contributor Aug 10, 2023

Stop chasing the hot flavors of the week and instead be friendly to your wallet with these ideas for best ESG stocks to buy.

Decibel Therapeutics (DBTX) Stock Skyrockets 71% on Regeneron Deal

By William White, InvestorPlace Writer Aug 9, 2023

Decibel Therapeutics (DBTX) stock is soaring higher on Wednesday after signing a deal with Regeneron Pharmaceuticals (REGN).

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

By Joel Baglole, InvestorPlace Contributor Aug 1, 2023

Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.

If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Jul 26, 2023

These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire.

3 Pharma Stocks That AI is Loving in July

By Chris Markoch, InvestorPlace Contributor Jul 13, 2023

Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now

By Josh Enomoto, InvestorPlace Contributor Jul 11, 2023

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

The 3 Best Biotech Stocks to Buy In July

By Joel Baglole, InvestorPlace Contributor Jul 5, 2023

With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.

How to Retire Rich: Biotech Stocks Edition

By Josh Enomoto, InvestorPlace Contributor Jun 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

3 Biotech Stocks to Sell in June Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Jun 6, 2023

The biotechnology sector has seen better days. From the Hedy days of the pandemic when companies were racing to develop a vaccine against Covid-19, the industry is now enduring a hangover as both demand and sales decline.

The 7 Growth Stocks You Need to Own Now for Maximum Returns

By Josh Enomoto, InvestorPlace Contributor May 17, 2023

If you still want to stick around in the market for max returns, these growth stocks to buy should be intriguing for speculators.

The Greatest 7 Blue-Chip Stocks to Buy for Your Portfolio

By Josh Enomoto, InvestorPlace Contributor Apr 20, 2023

With so many rumblings in the equities space, investors may be best served taking on the top blue-chip stocks to buy.

REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data

By William White, InvestorPlace Writer Mar 23, 2023

Regeneron Pharmaceuticals (REGN) stock is on the rise Thursday after the company released its latest clinical trial data on Dupixent.

7 Value Stocks Worth Buying at These 52-Week Highs

By Josh Enomoto, InvestorPlace Contributor Mar 22, 2023

While these value stocks are trading near their 52-week highs, they still have plenty of gas left in the tank for interested investors.

3 Biotech Stocks to Buy and Hold Through 2030 and Beyond

From The Motley Fool May 2, 2024

It pays to develop novel medicines for life-threatening illnesses.

2 Small-Cap Growth Stocks With Room To Run

From The Motley Fool Apr 24, 2024

These two small-cap growth stocks could be ready to run.

Should You Sell This Stock Following a Regulatory Roadblock?

From The Motley Fool Apr 5, 2024

It's not the first such obstacle this high-performing drugmaker has faced.

Stock-Split Watch: Are These 2 Top Growth Stocks Next?

From The Motley Fool Mar 28, 2024

Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.

Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.

From The Motley Fool Mar 9, 2024

Good news could be in store for all three of these drugmakers.

2 Biotech Stocks to Buy Hand Over Fist in March

From The Motley Fool Mar 8, 2024

These stocks are worth buying in most months of the year.

ADVERTISEMENT